Detection of carcinogen-induced bladder cancer by fluorocoxib A
Abstract Background Conventional cystoscopy can detect advanced stages of bladder cancer; however, it has limitations to detect bladder cancer at the early stages. Fluorocoxib A, a rhodamine-conjugated analog of indomethacin, is a novel fluorescent imaging agent that selectively targets cyclooxygena...
Main Authors: | Jennifer Bourn, Kusum Rathore, Robert Donnell, Wesley White, Md. Jashim Uddin, Lawrence Marnett, Maria Cekanova |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-11-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-019-6366-x |
Similar Items
-
Mutation Hotspots Found in Bladder Cancer Aid Prediction of Carcinogenic Risk in Normal Urothelium
by: Foster, B.A, et al.
Published: (2023) -
Detection of Non-Melanoma Skin Cancer by in vivo Fluorescence Imaging with Fluorocoxib A
by: Hyejun Ra, et al.
Published: (2015-02-01) -
Low-Level Arsenic Toxicity in Human Bladder Cells
by: Bredfeldt, Tiffany Gail
Published: (2006) -
Arsenic treatment increase Aurora-A overexpression through E2F1 activation in bladder cells
by: Yu-Ting Kao, et al.
Published: (2017-04-01) -
Primary enteric-type adenocarcinomas of the urinary bladder are histogenetically analogous to colorectal carcinomas: Immunohistochemical evaluation of 109 cases
by: Saad S. Eissa, et al.
Published: (2010-04-01)